Concentrix Corp·4

Mar 27, 8:50 AM ET

Deason Jennifer 4

4 · Concentrix Corp · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Concentrix (CNXC) Director Jennifer Deason Receives Award of 7,701 RSUs

What Happened

  • Jennifer Deason, a director of Concentrix Corporation (CNXC), received an award of 7,701 restricted stock units (RSUs) on 2026-03-25. The RSUs were reported as acquired at $0 (an award/grant rather than a purchase). These RSUs do not represent immediately transferable shares; they convert to common stock only upon vesting.

Key Details

  • Transaction date: 2026-03-25 (reported on Form 4 filed 2026-03-27).
  • Transaction type/code: Award/Grant (Code A).
  • Shares/units awarded: 7,701 RSUs; reported acquisition price $0 (award).
  • Vesting: RSUs vest in full on the earlier of (x) the one-year anniversary of the grant or (y) the date of the Issuer's 2027 Annual Meeting of Stockholders (per filing footnote).
  • Shares owned following the transaction: not specified in the provided filing details.
  • Tax withholding/other adjustments: none disclosed in the provided details.
  • Timeliness: Filing dated 2026-03-27 for a 2026-03-25 transaction — filed within the typical two-business-day Form 4 window.

Context

  • RSU awards are a common form of equity compensation for directors and typically convert to shares only when they vest; they are not an immediate open-market purchase or sale.
  • This award is compensation-related (not a purchase or sale) and should be viewed as part of director pay disclosures rather than a direct market-timing signal.

Insider Transaction Report

Form 4
Period: 2026-03-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-25+7,70117,704 total
Footnotes (1)
  • [F1]Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.
Signature
/s/ Andrew Farwig, Attorney-in-Fact|2026-03-27

Documents

1 file
  • 4
    wk-form4_1774615825.xmlPrimary

    FORM 4